Ami Fadia
Stock Analyst at Needham
(4.49)
# 298
Out of 5,049 analysts
400
Total ratings
51.93%
Success rate
21.9%
Average return
Main Sectors:
Stocks Rated by Ami Fadia
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AXSM Axsome Therapeutics | Reiterates: Buy | $154 | $134.93 | +14.13% | 17 | Nov 4, 2025 | |
| NBIX Neurocrine Biosciences | Maintains: Buy | $170 → $184 | $143.19 | +28.50% | 16 | Oct 29, 2025 | |
| ALKS Alkermes | Maintains: Buy | $43 → $44 | $30.39 | +44.78% | 4 | Oct 29, 2025 | |
| NMRA Neumora Therapeutics | Maintains: Buy | $6 → $8 | $2.79 | +186.74% | 10 | Oct 28, 2025 | |
| AVDL Avadel Pharmaceuticals | Downgrades: Hold | n/a | $18.90 | - | 37 | Oct 22, 2025 | |
| PRAX Praxis Precision Medicines | Maintains: Buy | $80 → $250 | $171.75 | +45.56% | 13 | Oct 16, 2025 | |
| GHRS GH Research | Initiates: Buy | $19 | $13.50 | +40.74% | 1 | Oct 13, 2025 | |
| ATAI Atai Life Sciences | Initiates: Buy | $12 | $5.28 | +127.27% | 1 | Oct 13, 2025 | |
| MNMD Mind Medicine (MindMed) | Initiates: Buy | $28 | $12.00 | +133.33% | 1 | Oct 13, 2025 | |
| IMRX Immuneering | Reiterates: Buy | $11 | $6.38 | +72.41% | 20 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $96 | $95.04 | +1.01% | 31 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $28 | $21.85 | +28.15% | 11 | Sep 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $48 → $41 | $30.72 | +33.46% | 38 | Sep 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $149.33 | - | 43 | Sep 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $56 → $66 | $58.57 | +12.69% | 26 | Sep 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $202 | $137.82 | +46.57% | 34 | Aug 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $16 | $7.30 | +119.18% | 21 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $14.13 | - | 23 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $23.74 | +47.43% | 1 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $29 | $6.87 | +322.13% | 21 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $240 → $320 | $15.20 | +2,005.26% | 2 | Feb 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $63 → $75 | $22.44 | +234.22% | 7 | Jan 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $15 → $23 | $0.61 | +3,577.07% | 4 | Oct 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $64 → $63 | $20.19 | +212.04% | 5 | Sep 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Market Perform | n/a | $20.46 | - | 9 | Oct 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $22 | $1.14 | +1,829.82% | 4 | Jan 3, 2018 |
Axsome Therapeutics
Nov 4, 2025
Reiterates: Buy
Price Target: $154
Current: $134.93
Upside: +14.13%
Neurocrine Biosciences
Oct 29, 2025
Maintains: Buy
Price Target: $170 → $184
Current: $143.19
Upside: +28.50%
Alkermes
Oct 29, 2025
Maintains: Buy
Price Target: $43 → $44
Current: $30.39
Upside: +44.78%
Neumora Therapeutics
Oct 28, 2025
Maintains: Buy
Price Target: $6 → $8
Current: $2.79
Upside: +186.74%
Avadel Pharmaceuticals
Oct 22, 2025
Downgrades: Hold
Price Target: n/a
Current: $18.90
Upside: -
Praxis Precision Medicines
Oct 16, 2025
Maintains: Buy
Price Target: $80 → $250
Current: $171.75
Upside: +45.56%
GH Research
Oct 13, 2025
Initiates: Buy
Price Target: $19
Current: $13.50
Upside: +40.74%
Atai Life Sciences
Oct 13, 2025
Initiates: Buy
Price Target: $12
Current: $5.28
Upside: +127.27%
Mind Medicine (MindMed)
Oct 13, 2025
Initiates: Buy
Price Target: $28
Current: $12.00
Upside: +133.33%
Immuneering
Sep 30, 2025
Reiterates: Buy
Price Target: $11
Current: $6.38
Upside: +72.41%
Sep 29, 2025
Downgrades: Hold
Price Target: $96
Current: $95.04
Upside: +1.01%
Sep 24, 2025
Maintains: Buy
Price Target: $30 → $28
Current: $21.85
Upside: +28.15%
Sep 24, 2025
Maintains: Buy
Price Target: $48 → $41
Current: $30.72
Upside: +33.46%
Sep 24, 2025
Reiterates: Hold
Price Target: n/a
Current: $149.33
Upside: -
Sep 11, 2025
Maintains: Buy
Price Target: $56 → $66
Current: $58.57
Upside: +12.69%
Aug 28, 2025
Reiterates: Buy
Price Target: $202
Current: $137.82
Upside: +46.57%
Aug 6, 2025
Maintains: Buy
Price Target: $18 → $16
Current: $7.30
Upside: +119.18%
Jun 17, 2025
Reiterates: Hold
Price Target: n/a
Current: $14.13
Upside: -
May 28, 2025
Initiates: Buy
Price Target: $35
Current: $23.74
Upside: +47.43%
May 2, 2025
Reiterates: Buy
Price Target: $29
Current: $6.87
Upside: +322.13%
Feb 1, 2021
Maintains: Outperform
Price Target: $240 → $320
Current: $15.20
Upside: +2,005.26%
Jan 21, 2021
Downgrades: Market Perform
Price Target: $63 → $75
Current: $22.44
Upside: +234.22%
Oct 1, 2020
Maintains: Market Perform
Price Target: $15 → $23
Current: $0.61
Upside: +3,577.07%
Sep 17, 2020
Maintains: Outperform
Price Target: $64 → $63
Current: $20.19
Upside: +212.04%
Oct 1, 2018
Upgrades: Market Perform
Price Target: n/a
Current: $20.46
Upside: -
Jan 3, 2018
Initiates: Outperform
Price Target: $22
Current: $1.14
Upside: +1,829.82%